Aurinia Pharmaceuticals Inc.
AUPH · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $283M | $235M | +20.4% |
| Operating income | $105M | −$4.69M | |
| Net income | $287M | $5.75M | +4,895% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 30, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $83.7M | $73.5M | +13.9% |
| Operating income | $35.4M | $29.7M | +19.2% |
| Net income | $31.7M | $31.6M | +0.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Aurinia's revenue in FY2025?
- $283M in FY2025 (Fiscal year ended Dec 31, 2025), +20.4% vs $235M a year earlier, per its 10-K filed Feb 2026.
- Was Aurinia profitable in FY2025?
- Yes: net income was $287M and operating income $105M in FY2025.
- What was Aurinia's revenue in Q3 2026?
- $83.7M (+13.9% vs a year earlier), per its Form 10-Q filed Oct 30, 2026.